Dynamic Light Scattering Study of Inhibition of Nucleation and Growth of Hydroxyapatite Crystals by Osteopontin

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  de Bruyn, John R ^a   Goiko, Maria ^a   Mozaffari, Maryam ^a   Bator, Daniel ^a   Dauphinee, Ron L ^a   Liao, Yinyin ^a   Flemming, Roberta L ^a   Bramble, Michael S ^a   Hunter, Graeme K ^a   Goldberg, Harvey A ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CALCIUM PHOSPHATE; CASEIN KINASE II; HYDROXYAPATITE; OSTEOPONTIN; PHOSPHATE; RECOMBINANT PROTEIN;

ANIMAL TISSUE; ARTICLE; BONE; CONTROLLED STUDY; CRYSTALLIZATION; LIGHT SCATTERING; NONHUMAN; PARTICLE SIZE; PRECIPITATION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; CRYSTALLIZATION; DURAPATITE; KINETICS; LIGHT; OSTEOPONTIN; PHOSPHORYLATION; PROTEIN ISOFORMS; RATS; SCATTERING, RADIATION;

EID: 84874010263     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056764     Document Type: Article

References (42)

1. Mann S (2001) Biomineralization: Principles and Concepts in Bioinorganic Materials Chemistry. Oxford: Oxford University Press.
2. George A, Veis A, (2008) Phosphorylated Proteins and Control over Apatite Nucleation, Crystal Growth, and Inhibition. Chem. Rev. 108: 4670-4693.
3. Addadi L, Weiner S, Geva M, (2001) On how proteins interact with crystals and their effect on crystal formation. Zeitschrift fur Kardiologie 90, Suppl. 3: 92-98.
4. De Yoreo JJ, Dove PM, (2004) Shaping crystals with biomolecules. Science 306: 1301-1302.
5. Giachelli CM, (2005) Inducers and inhibitors of biomineralization: lessons from pathological calcification. Orthod. Craniofac. Res 8: 229-231.
6. Lowenstam HA, Weiner S (1989) On Biomineralization, Oxford: Oxford University Press.
7. Shiraga H, Min W, Van Dusen WJ, Clayman MD, Miner D, et al. (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid-rich protein superfamily. Proc. Nat. Acad. Sci. USA 89: 426-430.
8. Boskey AL, Maresca M, Ulirich W, Doty SB, Butler WT, et al. (1993) Osteopontin-hydroxyapatite interactions in vitro. Inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner 22: 147-159.
9. Hunter GK, Kyle CL, Goldberg HA, (1994) Modulation of Crystal Formation by Bone Phosphoproteins: Structural Specificity of the Osteopontin-Mediated Inhibition of Hydroxyapatite Formation. Biochem. J 300: 723-728.
10. Fisher LW, Torchia DA, Fohr B, Young MF, Fedarko NS, (2001) Flexible structures of SIBLING proteins, bone sialoprotein and osteopontin. Biochem. Biophys. Res. Comm 280: 460-465.
11. Butler WT, (1995) Structural and functional domains of osteopontin. Ann. N.Y. Acad. Sci 760: 6-11.
12. Keykhosravani M, Doherty-Kirby A, Zhang C, Brewer D, Goldberg HA, et al. (2005) Comprehensive identification of post-translational modifications of rat bone osteopontin by mass spectrometry. Biochemistry 44: 6990-7003.
13. Grohe B, Taller A, Vincent PL, Tieu LD, Rogers KA, et al. (2009) Crystallization of calcium oxalates is controlled by molecular hydrophilicity and specific polyanion-crystal interactions. Langmuir 25: 11635-11646.
14. Pampena DA, Robertson KA, Litvinova O, Lajoie G, Goldberg HA, et al. (2004) Inhibition of hydroxyapatite formation by osteopontin phosphopeptides. Biochem. J 378: 1083-1087.
15. Azzopardi PV, O'Young J, Lajoie G, Karttunen M, Goldberg HA, et al. (2010) Roles of Electrostatics and Conformation in Protein-Crystal Interactions. PLoS One. 5: e9330 1-11.
16. Hincke MT, St. Maurice M (2000) Phosphorylation-dependent modulation of calcium carbonate precipitation by chicken eggshell matrix proteins. In: Goldberg M, Boskey A, Robinson C, editors. Chemistry and biology of mineralized tissues, Rosemount: American Academy of Orthopaedic Surgeons. pp. 13-17.
17. Hoyer JR, Asplin JR, Otvos L, (2001) Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals. Kidney International 60: 77-82.
18. Gericke A, Qin C, Spevak L, Fujimoto Y, Butler WT, et al. (2005) Importance of phosphorylation for osteopontin regulation of biomineralization. Calcif. Tissue Int 77: 45-54.
19. Wang L, Guan X, Tang R, Hoyer JR, Wierzbicki A, et al. (2008) Phosphorylation of osteopontin is required for inhibition of calcium oxalate crystallization. J. Phys. Chem.B 112: 9151-9157.
20. Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA, (1996) Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem. J 317: 59-64.
21. Tomson MB, Nancollas GH, (1978) Mineralization kinetics: a constant composition approach. Science 200: 1059-1060.
22. O'Young J, Liao Y, Xiao Y, Jalkanen J, Lajoie G, et al. (2011) Matrix Gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals. J. Am. Chem. Soc 133: 18406-18412.
23. Boskey AL, (1992) Mineral-matrix interactions in bone and cartilage. Orthop. Relat. Res 281: 244-274.
24. Onuma K, Oyane A, Tsutsui K, Tanaka K, Treboux G, et al. (2000) Precipitation kinetics of hydroxyapatite revealed by the continuous-angle laser light-scattering technique. J. Phys. Chem.B 104: 10563-10568.
25. Onuma K, Ito A, (1998) Cluster growth model for hydroxyapatite. Chem. Mater 10: 3346-3351.
26. Oyane A, Onuma K, Kokubo T, Ito A, (1999) Clustering of calcium phosphate in the system CaCl2-H3PO4-KCl-H2O. J. Phys. Chem.B 103: 8230-8235.
27. Heiss A, DuChesne A, Denecke B, Grötzinger J, Yamamoto K, et al. (2003) Structural basis of calcium inhibition by α2-HS glycoprotein/fetuin A. J. Biol. Chem 278: 13333-13341.
28. Kamiya N, Tsunomori F, Kagi H, Notsu K, (2011) Dynamic light scattering study of the inhibiting effect on crystal growth of calcium carbonate. Bull. Chem. Soc. Jpn 84: 344-348.
29. Zhang Q, Domenicucci C, Wrana JL, Sodek J, (1990) Characterization of fetal porcine bone sialoproteins, secreted phosphoprotein I (SPPI, osteopontin), bone sialoprotein, and a 23-kDa glycoprotein. Demonstration that the 23-kDa glycoprotein is derived from the carboxyl terminus of SPPI. J. Biol. Chem 265: 7583-7589.
30. Baht GS, O'Young J, Borovina A, Chen H, Tye CE, et al. (2010) Phosphorylation of Ser136 is critical for potent bone sialoprotein-mediated nucleation of hydroxyapatite crystals. Biochem. J 428: 385-395.
31. Flemming RL, (2007) Micro X-ray Diffraction (μXRD): A versatile technique for characterization of Earth and planetary materials. Can. J. Earth Sci 44: 1333-1346.
32. Berne BJ, Pecora R (1976) Dynamic Light Scattering: with Applications to Chemistry, Biology, and Physics. New York: Wiley.
33. Xu R (2000) Particle characterization: light scattering methods. Dordrecht: Kluwer.
34. ALV-GmbH website. Available: http://www.alvgmbh.de/About_ALV/about_alv.html. Langen, Germany.
35. Frisken BJ, (2001) Revisiting the method of cumulants for the analysis of dynamic light-scattering data. Applied Optics 40: 4087-4091.
36. Nancollas GH, Mohan MS, (1970) The growth of hydroxyapatite crystals. Arch. Oral Biol 15: 731-745.
37. Provencher SW, (1982) CONTIN: A general purpose constrained regularization program for inverting noisy linear algebraic and integral equations. Comput. Phys. Comm 27: 229-242.
38. Marino I-G (2007) Available: http://www.mathworks.com/matlabcentral/fileexchange/6523-rilt. Accessed 2010 Apr 5.
39. Li S, Wang L, (2012) Phosphorylated osteopontin peptides inhibit crystallization by resisting the aggregation of calcium phosphate nanoparticles. Cryst. Eng. Comm 14: 8037-8043.
40. Grohe B, O'Young J, Ionescu DA, Lajoie G, Rogers KA, et al. (2007) Control of calcium oxalate crystal growth by face-specific adsorption of an osteopontin phosphopeptide. J. Amer. Chem. Soc 129: 14946-14951.
41. Singh K, Deonarine D, Shanmugam V, Senger DR, Mukherjee AB, et al. (1993) Calcium-binding properties of osteopontin derived from non-osteogenic sources. J. Biochem 114: 702-707.
42. Chen Y, Bal BS, Gorski JP, (1992) Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone. J. Biol. Chem 267: 24871-24878.